Effects of selected antihypertensives and analgesics on hepatic porphyrin accumulation accumulation. Implications for clinical porphyria

Biochemical Pharmacology

Volumn 58, Issue 5, 1999, Pages 887-896

  Lambrecht, Richard W ^a   Gildemeister, Otto S ^a,b   Williams, Alyssa ^a,b   Pepe, Joyce A ^a,b   Tortorelli, Kristina D ^a,b   Bonkovsky, Herbert L ^a,b  

^a UNIVERSITY OF MASSACHUSETTS MEDICAL SCHOOL   (United States)

^b Ctr Stud Disord Iron Porphyrin M   (United States)

Author keywords

5 Aminolevulinate synthase; Acute porphyria; Analgesics; Antihypertensives; Liver cells; Porphyrin accumulation

Indexed keywords

5 AMINOLEVULINATE SYNTHASE; ANALGESIC AGENT; ANTIHYPERTENSIVE AGENT; BUPRENORPHINE; CALCIUM CHANNEL BLOCKING AGENT; CAPTOPRIL; DEFEROXAMINE; DEZOCINE; DILTIAZEM; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; ENALAPRIL; FENTANYL; FENTANYL CITRATE; HYDROCODONE; LISINOPRIL; LOSARTAN; MORPHINE; NALBUPHINE; NIFEDIPINE; OXYCODONE; PORPHYRIN; TRAMADOL;

ACUTE INTERMITTENT PORPHYRIA; ANIMAL CELL; ARTICLE; CHICK EMBRYO; CONTROLLED STUDY; LIVER CELL; NONHUMAN; PORPHYRIA; PRIORITY JOURNAL;

ANALGESICS; ANIMALS; ANTIHYPERTENSIVE AGENTS; CELLS, CULTURED; CHICK EMBRYO; LIVER; PORPHYRIAS, HEPATIC; PORPHYRINS;

EID: 0032807796     PISSN: 00062952     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0006-2952(99)00154-9     Document Type: Article

References (39)

1. Kappas A., Sassa S., Galbraith R.A., Nordmann Y. The porphyrias. Scriver C.R., Beaudet A.L., Sly W.S., Valle D. The Metabolic Basis of Inherited Disease. 7th Edn :1995;2103-2160 McGraw-Hill, New York.
2. Hahn M and Bonkovsky HL, Disorders of porphyrin metabolism. In: Diseases of the Liver and Bile Ducts. A Practical Guide to Diagnosis and Treatment (Eds. Wu GY and Israel J), pp. 249-272. Humana Press, Totowa, NJ, 1998.
3. Drew P.D., Ades I.Z. Regulation of the stability of chicken embryo liver δ-aminolevulinate synthase mRNA by hemin. Biochem Biophys Res Commun. 162:1989;102-107.
4. Hamilton J.W., Bement W.J., Sinclair P.R., Sinclair J.F., Alcedo J.A., Wetterhahn K.E. Heme regulates hepatic 5-aminolevulinate synthase mRNA expression by decreasing mRNA half-life and not by altering its rate of transcription. Arch Biochem Biophys. 289:1991;387-392.
5. Cable E.E., Cable J.W., Bonkovsky H.L. Repression of hepatic δ-aminolevulinate synthase by heme and metalloporphyrins Relationship to inhibition of heme oxygenase . Hepatology. 18:1993;119-127.
6. Cable E.E., Pepe J.A., Karamitsios N.C., Lambrecht R.W., Bonkovsky H.L. Differential effects of metalloporphyrins on messenger RNA levels of δ-aminolevulinate synthase and heme oxygenase. Studies in cultured chick embryo liver cells. J Clin Invest. 94:1994;649-654.
7. Cable E.E., Gildemeister O.S., Pepe J.A., Donohue S.E., Lambrecht R.W., Bonkovsky H.L. Hepatic 5-aminolevulinic acid synthase mRNA stability is modulated by inhibitors of heme biosynthesis and by metalloporphyrins. Eur J Biochem. 240:1996;112-117.
8. Ades I.Z., Harpe K.G. Biogenesis of mitochondrial proteins. Identification of the mature and precursor forms of the subunit of δ-aminolevulinate synthase from embryonic chick liver. J Biol Chem. 256:1981;9329-9333.
9. Lathrop J.T., Timko M.P. Regulation by heme of mitochondrial protein transport through a conserved amino acid motif. Science. 259:1993;522-525.
10. Moore M.R. International review of drugs in acute porphyria - 1980. Int J Biochem. 12:1980;1089-1097.
11. Hamilton JW, Bement WJ, Sinclair PR, Sinclair JF and Wetterhahn KE, Expression of 5-aminolaevulinate synthase and cytochrome P-450 mRNAs in chicken embryo hepatocytes in vivo and in culture. Effect of porphyrinogenic drugs and haem [published erratum appears in Biochem J 257: following 934, 1989]. Biochem J 255: 267-275, 1988.
12. Ryan G., Ades I.Z. Coordinate elevations of liver δ-aminolevulinate synthase and cytochrome P-450 RNA by phenobarbital in chicken embryos The effects of heme . Int J Biochem. 21:1989;1025-1031.
13. Hahn M., Gildemeister O.S., Krauss G.L., Pepe J.A., Lambrecht R.W., Donohue S., Bonkovsky H.L. Effects of new anticonvulsant medications on porphyrin synthesis in cultured liver cells Potential implications for patients with acute porphyria . Neurology. 49:1997;97-106.
14. Cable E.E., Healey J.F., Greene Y., Evans C.-O., Bonkovsky H.L. Synergistic induction of δ-aminolevulinate synthase by glutethimide and iron Relationship to the synergistic induction of heme oxygenase . Biochim Biophys Acta. 1080:1991;245-251.
15. Bonkovsky H.L., Cable E.E., Cable J.W., Donohue S.E., White E.C., Greene Y.J., Lambrecht R.W., Srivastava K.K., Arnold W.N. Porphyrogenic properties of the terpenes camphor, pinene, and thujone (with a note on historic implications for absinthe and the illness of Vincent van Gogh). Biochem Pharmacol. 43:1992;2359-2368.
16. Cable E.E., Pepe J.A., Donohue S.E., Lambrecht R.W., Bonkovsky H.L. Effects of mifepristone (RU-486) on heme metabolism and cytochromes P-450 in cultured chick embryo liver cells, possible implications for acute porphyria. Eur J Biochem. 225:1994;651-657.
17. Grandchamp B., Deybach J.C., Grelier M., De Verneuil H., Nordmann Y. Studies of porphyrin synthesis in fibroblasts of patients with congenital erythropoietic coproporphyria and one patient with homozygous coproporphyria. Biochim Biophys Acta. 629:1980;577-586.
18. Bonkovsky H.L., Sinclair P.R., Lambrecht R.W., Bement W.J., Sinclair J.F. Role of cytochrome P450 in porphyria caused by halogenated aromatic compounds. Ann NY Acad Sci. 514:1987;96-112.
19. Sinclair P.R., Bement W.J., Bonkovsky H.L., Lambrecht R.W., Frezza J.E., Sinclair J.F., Urquhart A.J., Elder G.H. Uroporphyrin accumulation produced by halogenated biphenyls in chick-embryo hepatocytes. Reversal of the accumulation by piperonyl butoxide. Biochem J. 237:1986;63-71.
20. Eales L. Porphyria and the dangerous life-threatening drugs. S Afr Med J. 56:1979;914-917.
21. Moore M.R., McColl K.E.L. Therapy of the acute porphyrias. Clin Biochem. 22:1989;181-188.
22. Moore M.R., Hift R.J. Drugs in the acute porphyrias - toxicogenetic diseases. Cell Mol Biol. 43:1997;89-94.
23. Ashley E.M.C. Anaesthesia for porphyria. Br J Hosp Med. 56:1996;37-42.
24. Dover S.B., Plenderleith L., Moore M.R., McColl K.E.L. Safety of general anaesthesia and surgery in acute hepatic porphyria. Gut. 35:1994;1112-1115.
25. Gorchein A. Drug treatment in acute porphyria. Br J Clin Pharmacol. 44:1997;427-434.
26. Kalman D.R., Bonkovsky H.L. Management of acute attacks in the porphyrias. Clin Dermatol. 16:1998;299-306.
27. Goerz G., Bolsen K., Böhrer H., Fritsch C., Kalka K., Rominger K.L. Effects of clonidine in a primed rat model of acute hepatic porphyria. Arzneimittelforschung. 47:1997;731-733.
28. Lindberg R.L.P., Porcher C., Grandchamp B., Ledermann B., Bürki K., Brandner S., Aguzzi A., Meyer U.A. Porphobilinogen deaminase deficiency in mice causes a neuropathy resembling that of human hepatic porphyria. Nat Genet. 12:1996;195-199.
29. Granick S. The induction in vitro of the synthesis of δ-aminolevulinic acid synthetase in chemical porphyria A response to certain drugs, sex hormones, and foreign chemicals . J Biol Chem. 241:1966;1359-1375.
30. Tschudy D.P., Bonkowsky H.L. Experimental porphyria. Fedn Proc. 31:1972;147-159.
31. Schoenfeld N., Aelion J., Beigel Y., Epstein O., Atsmon A. The porphyrogenic effects of calcium channel blocking drugs. Clin Sci. 69:1985;581-586.
32. Marks G.S., Goldman D.R., McClusky S.A., Sutherland E.P., Lyon M.E. The effects of dihydropyridine calcium antagonists on heme biosynthesis in chick embryo liver cell culture. Can J Physiol Pharmacol. 64:1986;438-443.
33. Marks G.S., Powles J., Lyon M., McClusky S., Sutherland E., Zelt D. Patterns of porphyrin accumulation in response to xenobiotics. Parallels between results in chick embryo and rodents. Ann NY Acad Sci. 514:1987;113-127.
34. Healey J.F., Bonkowsky H.L., Sinclair P.R., Sinclair J.F. Conversion of 5-aminolevulinate into haem by liver homogenates Comparison of rat and chick embryos . Biochem J. 198:1981;595-604.
35. Bonkovsky H.L., Healey J.F., Sinclair P.R., Sinclair J.F. Conversion of 5-aminolevulinate into haem by homogenates of human liver Comparison with rat and chick embryo liver homogenates . Biochem J. 227:1985;893-901.
36. Lambrecht R.W., Sinclair P.R., Bement W.J., Sinclair J.F., Carpenter H.M., Buhler D.R., Urquhart A.J., Elder G.H. Hepatic uroporphyrin accumulation and uroporphyrinogen decarboxylase activity in cultured chick-embryo hepatocytes and Japanese quail (Coturnix coturnix japonica) and mice treated with polyhalogenated aromatic compounds. Biochem J. 253:1988;131-138.
37. Lyon M.E., Owen J.A., Marks G.S. Xenobiotic mediated inhibition of hepatic uroporphyrinogen decarboxylase activity in 17-day-old chick embryo liver cells in culture. Biochem Pharmacol. 37:1988;1123-1129.
38. Bhadoria D.P., Srivastava A.K., Sharma M., Deswal A., Bhadoria P., Malhotra K.K. Safe use of clonidine, nifedepine and vitamin K in hepatic porphyria. J Assoc Physicians India. 36:1988;675-676.
39. Koleva M., Stoytchev T. On the enzyme-inducing action of calcium antagonists. Arch Toxicol. 67:1993;294-296.